Evaluating the efficacy and safety of transcutaneous vagus nerve stimulation for systemic lupus erythematosus: a protocol for a systematic review and meta-analysis.

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that causes inflammation throughout the body, leading to fatigue, pain, and other debilitating symptoms. Traditional treatments often involve powerful immunosuppressant medications that can cause significant side effects. Researchers are now investigating whether transcutaneous vagus nerve stimulation (tVNS)—a technique that uses mild electrical impulses applied to the skin near the vagus nerve—might offer a safer alternative treatment option.

This study is actually a protocol for a systematic review, meaning researchers are planning to examine all existing clinical trials on tVNS for lupus to determine whether this therapy is both effective and safe. They will search multiple medical databases for studies that measured outcomes like fatigue (the primary focus), pain levels, quality of life, mood, and disease activity markers in SLE patients. The research team will carefully analyze the quality of each study and combine the results to see if tVNS shows real promise as an add-on therapy for lupus.

While tVNS is related to the broader field of neuromodulation rather than traditional acupuncture, both approaches share the concept of stimulating specific body points to influence nervous system function and reduce inflammation. For acupuncture patients with autoimmune conditions, this research highlights the growing scientific interest in electrical stimulation therapies that work through similar pathways. The findings from this future review may help determine whether tVNS could complement existing lupus treatments with fewer side effects than conventional medications. If you're considering any complementary therapy for autoimmune conditions, it's essential to work with a qualified, licensed acupuncturist who can coordinate care with your rheumatologist.

This systematic review protocol outlines a comprehensive evaluation of transcutaneous vagus nerve stimulation (tVNS) efficacy and safety for systemic lupus erythematosus. Researchers will search eight databases (PubMed, Cochrane, Web of Science, Embase, and four Chinese databases) for relevant clinical trials including RCTs. The primary outcome is fatigue, with secondary outcomes encompassing pain, quality of life, negative emotions, adverse events, and SLE disease activity measures. Two independent reviewers will conduct data selection, extraction, and quality assessment using appropriate risk of bias tools. Evidence quality will be evaluated via GRADE methodology, and meta-analysis will be performed using RevMan 5.4.1, with planned subgroup, sensitivity, and meta-regression analyses. This protocol addresses the clinical need for safer adjunctive therapies in SLE management, given immunosuppressants' significant adverse effect profiles. The neuromodulatory mechanisms of tVNS may parallel electroacupuncture's anti-inflammatory pathways, offering relevant insights for integrative practitioners managing autoimmune conditions. Sample sizes and effect sizes will be determined upon completion of the actual review.